These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32520230)

  • 1. Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential.
    Sousa JCE; Santana ACF; MagalhÃes GJP
    Arq Neuropsiquiatr; 2020 Jun; 78(8):501-511. PubMed ID: 32520230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials.
    Tosatti JAG; Fontes AFDS; Caramelli P; Gomes KB
    Drugs Aging; 2022 Apr; 39(4):285-295. PubMed ID: 35187615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1.
    Gomes BAQ; Silva JPB; Romeiro CFR; Dos Santos SM; Rodrigues CA; Gonçalves PR; Sakai JT; Mendes PFS; Varela ELP; Monteiro MC
    Oxid Med Cell Longev; 2018; 2018():8152373. PubMed ID: 30510627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
    Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
    Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease.
    Komorowska J; Wątroba M; Szukiewicz D
    Adv Med Sci; 2020 Sep; 65(2):415-423. PubMed ID: 32871321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of resveratrol in Alzheimer disease pathology.
    Rege SD; Geetha T; Griffin GD; Broderick TL; Babu JR
    Front Aging Neurosci; 2014; 6():218. PubMed ID: 25309423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress on Alzheimer's Disease and Resveratrol.
    Yan Y; Yang H; Xie Y; Ding Y; Kong D; Yu H
    Neurochem Res; 2020 May; 45(5):989-1006. PubMed ID: 32162143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of resveratrol in Alzheimer's disease.
    Rao YL; Ganaraja B; Joy T; Pai MM; Ullal SD; Murlimanju BV
    Front Biosci (Elite Ed); 2020 Jan; 12(1):139-149. PubMed ID: 31585875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol in experimental Alzheimer's disease models: A systematic review of preclinical studies.
    Chen JY; Zhu Q; Zhang S; OuYang D; Lu JH
    Pharmacol Res; 2019 Dec; 150():104476. PubMed ID: 31605783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease.
    Braidy N; Jugder BE; Poljak A; Jayasena T; Mansour H; Nabavi SM; Sachdev P; Grant R
    Curr Top Med Chem; 2016; 16(17):1951-60. PubMed ID: 26845555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics.
    Cassidy L; Fernandez F; Johnson JB; Naiker M; Owoola AG; Broszczak DA
    Complement Ther Med; 2020 Mar; 49():102294. PubMed ID: 32147039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer's Disease Treatment.
    Knight E; Geetha T; Broderick TL; Babu JR
    Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol, Metabolic Dysregulation, and Alzheimer's Disease: Considerations for Neurogenerative Disease.
    Yang AJT; Bagit A; MacPherson REK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence.
    Lejri I; Agapouda A; Grimm A; Eckert A
    Oxid Med Cell Longev; 2019; 2019():9695412. PubMed ID: 31214285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation.
    Zhang M; Tang Z
    Biomed Pharmacother; 2023 May; 161():114474. PubMed ID: 36878051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical interaction of resveratrol with sirtuin pathway: Significance in Alzheimer's disease.
    Mohan S; Gobinath T; Salomy A; Nisha M; Kandasamy M; Essa MM; Jayachandran KS; Anusuyadevi M
    Front Biosci (Landmark Ed); 2018 Mar; 23(7):1380-1390. PubMed ID: 29293440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases?
    Ribeiro R; Santos AC; Calazans MO; De Oliveira ACP; Vieira LB
    Nutr Neurosci; 2022 Nov; 25(11):2442-2457. PubMed ID: 34514962
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural antioxidants in Alzheimer's disease.
    Mancuso C; Bates TE; Butterfield DA; Calafato S; Cornelius C; De Lorenzo A; Dinkova Kostova AT; Calabrese V
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1921-31. PubMed ID: 18042001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.